Archives for March 2008
Fighting Disfiguring Dermatologic Side Effects Of Cancer Treatment
Becky Sasaki has the quick laugh and easy smile of a woman who continues to thrive despite her four-year wrestling match with lung cancer. She still works every day in the family business, heads out for Thai food with her husband and baby sits for her energetic grandchildren.This winter when the cancer, which had metastasized, [...]
American Academy Of Dermatology Issues Statement Urging The Public To Be Sun Smart(SM)
For decades, the American Academy of Dermatology has advised the public to practice proper sun protection to prevent skin cancer — and that same advice holds true today, despite any claims to the contrary. “While the health benefits of vitamin D are well known, it also is well known that exposure to [...]
Silk’n(TM) Personal Light-Based Hair Removal Device Cleared By FDA
Home Skinovations Ltd. announced that the Silk’n™ device was cleared by the United States Food and Drug Administration (FDA) for home-based removal of unwanted hair under the direction of a physician. Silk’n™, powered by the innovative and proprietary Home Pulsed Light™ technology (HPL™), is clinically tested and physician approved for safe, quick, and effective removal [...]
Anacor Pharmaceuticals Announces Positive Results From Phase 2a Clinical Trial Of AN2728 In Psoriasis Patients
Anacor Pharmaceuticals announced results from a Phase 2a clinical trial of AN2728, an investigational topical anti-inflammatory drug, in patients with psoriasis. The study met its primary endpoint and all secondary endpoints. In 69 percent of patients, the area treated with AN2728 scored better at the end of therapy than the [...]
Romanian Community Provides Insight Into Genetic Factors Associated With Vitiligo
An isolated, inbred Romanian community has a higher than average frequency of the skin disease vitiligo and other autoimmune diseases, suggesting a genetic variation that may indicate susceptibility to the condition in a broader population, according to a report in the March issue of Archives of Dermatology, one of the JAMA/Archives journals.
Original post by [...]
Younger Age, Involvement On Neck Or Arms Associated With Abnormal Scarring After Burn Injury
Sex, age, burn site, number of surgical procedures and the type of skin graft are associated with abnormal scarring following burns, according to a report in the March/April 2008 issue of Archives of Facial Plastic Surgery, one of the JAMA/Archives journals. The survival rate of patients with burns has dramatically increased over the [...]
Traditional Chinese Herbal Medicine May Benefit Eczema Patients
A traditional Chinese herbal medicine consisting of five herbs may benefit people with eczema, new research in the British Journal of Dermatology will reveal. Scientists at the Chinese University of Hong Kong evaluated the effects of ‘pentaherbs formulation’ on patients aged between five and 21 with atopic eczema, the most common type of the disease [...]
Research Shows Patients With Psoriasis At Increased Risk For Developing Other Serious Medical Conditions
It has long been known that psoriasis, a chronic skin condition characterized by thick, red, scaly plaques that itch and bleed, can have a significant negative impact on a patient’s overall quality of life. Now, dermatologists are finding that psoriasis, especially severe psoriasis, is linked with a number of serious medical conditions — including cardiovascular [...]
Pharmamar Initiates A Phase II Study Of Yondelis® In Children With Recurrent Soft Tissue Sarcomas
PharmaMar announces the initiation of a Phase II multicenterstudy of Yondelis® (trabectedin) in children with recurrent rhabdomyosarcoma, Ewing´ssarcoma, or non-rhabdomyosarcomatous soft tissue sarcomas. The study will determine a safe and tolerable dose of Yondelis in pediatric patients and assessthe efficacy at that dose based on response rates. Additionally, toxicity and pharmacokineticsin these patients will be [...]
Baxter Announces FDA Approval Of ARTISS Slow Setting Fibrin Sealant In Treatment Of Burn Patients
Baxter Healthcare Corporation announced the U.S. Food and Drug Administration (FDA) approval of ARTISS (Fibrin Sealant (Human)), the first and only slow-setting fibrin sealant indicated for use in adhering skin grafts in adult and pediatric burn patients. ARTISS was developed using Baxter’s proven fibrin sealant technology platform and is the newest agent in the [...]